The role of CC chemokine receptor 5 in antiviral immunity

scientific article published on 01 February 2002

The role of CC chemokine receptor 5 in antiviral immunity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1182/BLOOD.V99.4.1237
P698PubMed publication ID11830471

P50authorAllan Randrup ThomsenQ30127185
Jan Pravsgaard ChristensenQ43182017
P2093author name stringChristina Bartholdy
Jeanette Erbo Christensen
Anneline Nansen
Susanne Ørding Andreasen
P2860cites workIdentification of a major co-receptor for primary isolates of HIV-1Q22251282
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)1237-1245
P577publication date2002-02-01
P1433published inBloodQ885070
P1476titleThe role of CC chemokine receptor 5 in antiviral immunity
P478volume99

Reverse relations

cites work (P2860)
Q33908877Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2
Q45663708Blocking CC chemokine receptor (CCR) 1 and CCR5 during herpes simplex virus type 2 infection in vivo impairs host defence and perturbs the cytokine response
Q40433578CCR5 Polymorphism as a Protective Factor for Hepatocellular Carcinoma in Hepatitis B Virus-Infected Iranian Patients
Q27468933CCR5 ameliorates Japanese encephalitis via dictating the equilibrium of regulatory CD4+Foxp3+ T and IL-17+CD4+ Th17 cells
Q36098944CCR5 and CXCR3 are dispensable for liver infiltration, but CCR5 protects against virus-induced T-cell-mediated hepatic steatosis
Q38702121CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.
Q97550828CCR5 Δ32 minorallele is associated with susceptibility to SARS-CoV-2 infection and death: An epidemiological investigation
Q37358025CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality
Q24646031Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection
Q58064957Chemokine receptor genotype and response to interleukin-2 therapy in HIV-1-infected individuals
Q36981179Chemokines and Chemokine Receptors Critical to Host Resistance following Genital Herpes Simplex Virus Type 2 (HSV-2) Infection
Q34761117Circulating herpes simplex type 1 (HSV-1)-specific CD8+ T cells do not access HSV-1 latently infected trigeminal ganglia.
Q34059483Defining the chemokine basis for leukocyte recruitment during viral encephalitis
Q42984759Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.
Q43023517Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.
Q47581613Efficient T-cell surveillance of the CNS requires expression of the CXC chemokine receptor 3.
Q35209368Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function
Q45722206Functional analysis of the CC chemokine receptor 5 (CCR5) on virus-specific CD8+ T cells following coronavirus infection of the central nervous system
Q35634901Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence
Q28188558HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors
Q50351898Identification of Shared Molecular Signatures Indicate the Susceptibility of Endometriosis to Multiple Sclerosis
Q37287603Influence of the CCR-5/MIP-1 α axis in the pathogenesis of Rocio virus encephalitis in a mouse model
Q35048826Knock out models to dissect chemokine receptor function in vivo
Q63246385Local Antigen Encounter Is Essential for Establishing Persistent CD8 T-Cell Memory in the CNS
Q37175343Lymphocytic choriomeningitis infection of the central nervous system
Q37267001Lymphocytic choriomeningitis virus-induced central nervous system disease: a model for studying the role of chemokines in regulating the acute antiviral CD8+ T-cell response in an immune-privileged organ
Q37101154Multistrain genetic comparisons reveal CCR5 as a receptor involved in airway hyperresponsiveness
Q40639381Novel interfering bifunctional molecules against the CCR5 coreceptor are efficient inhibitors of HIV-1 infection
Q37678456Possible Impact of 190G > A CCR2 and Δ32 CCR5 Mutations on Decrease of the HBV Vaccine Immunogenicity-A Preliminary Report
Q36944914RNA interference and antiviral therapy.
Q35044766Regulation of T cell migration during viral infection: role of adhesion molecules and chemokines
Q44394482Role of CCR5Δ32 mutation in protecting patients with Schistosoma mansoni infection against hepatitis C viral infection or progression
Q27490393Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection
Q40133015Role of macrophage inflammatory protein-1alpha in T-cell-mediated immunity to viral infection
Q35149275Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages
Q27477986The CCR5- 32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source
Q34427503The chemokine receptor CCR5, a therapeutic target for HIV/AIDS antagonists, is critical for recovery in a mouse model of Japanese encephalitis
Q36606525The expression of the chemokine receptor CCR5 in tick-borne encephalitis.
Q34726185The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection
Q35960061The role of CCR5 in HCV infection
Q35149350The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation
Q34362854Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.
Q33642954α4-integrins control viral meningoencephalitis through differential recruitment of T helper cell subsets.

Search more.